Publication | Open Access

The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life

Medicinal ChemistryNovel Benzopyran ClassFavorable Human Half-lifePharmacologyMechanism Of ActionPharmacological AgentPharmacotherapySelective Cyclooxygenase-2 InhibitorsAnti-cancer AgentDrug DevelopmentMedicinePharmaceutical ChemistryDrug DiscoveryDrug Resistance